Literature DB >> 20123467

White matter pathology in phenylketonuria.

Peter J Anderson1, Vincenzo Leuzzi.   

Abstract

Early-treated phenylketonuria (PKU) is associated with a range of neuropsychological impairments. Proposed mechanisms for these impairments include dopamine depletion and white matter pathology. Neuroimaging studies demonstrate high-signal intensity in the periventricular white matter in most PKU patients, which can extend into subcortical and frontal regions in more severe cases. A review of histopathology and neuroimaging studies reveals that diffuse white matter pathology in untreated PKU patients is likely to reflect hypomyelination (lack of myelin formation), while in early-treated patients white matter abnormalities observed on magnetic resonance imaging (MRI) is likely to reflect intramyelinic edema. Research demonstrates that this pathology is associated with metabolic control and may be reversed with adherence to a strict low-phenylalanine (Phe) diet. While the functional significance of white matter pathology in PKU is not certain, there is some evidence that these abnormalities are associated with functional impairments when the pathology extends into subcortical and frontal regions. Crown Copyright 2009. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20123467     DOI: 10.1016/j.ymgme.2009.10.005

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  49 in total

1.  Unusual presentation of two Chinese phenylketonuria sisters who were misdiagnosed for years.

Authors:  Xiaomei Liu; Hui Guo; Mahesh Dahal; Bingyin Shi
Journal:  BMJ Case Rep       Date:  2013-09-24

2.  Sight-threatening phenylketonuric encephalopathy in a young adult, reversed by diet.

Authors:  S Rubin; A L Le Piffer; M B Rougier; M N Delyfer; J F Korobelnik; I Redonnet-Vernhet; C Marchal; C Goizet; S Mesli; C Gonzalez; H Gin; V Rigalleau
Journal:  JIMD Rep       Date:  2013-02-12

3.  Adult-onset phenylketonuria revealed by acute reversible dementia, prosopagnosia and parkinsonism.

Authors:  Francesca Rosini; Alessandra Rufa; Lucia Monti; Letizia Tirelli; Antonio Federico
Journal:  J Neurol       Date:  2014-10-31       Impact factor: 4.849

4.  Diffusion tensor imaging detects areas of abnormal white matter microstructure in patients with partial ornithine transcarbamylase deficiency.

Authors:  A L Gropman; B Gertz; K Shattuck; I L Kahn; R Seltzer; L Krivitsky; J Van Meter
Journal:  AJNR Am J Neuroradiol       Date:  2010-05-20       Impact factor: 3.825

5.  Developmental Trajectories of Executive and Verbal Processes in Children with Phenylketonuria.

Authors:  Zoë W Hawks; Michael J Strube; Neco X Johnson; Dorothy K Grange; Desirée A White
Journal:  Dev Neuropsychol       Date:  2018-02-12       Impact factor: 2.253

6.  Sapropterin hydrochloride: enzyme enhancement therapy for phenylketonuria.

Authors:  Robin Lachmann
Journal:  Ther Adv Endocrinol Metab       Date:  2011-06       Impact factor: 3.565

7.  Tract-based evaluation of white matter damage in individuals with early-treated phenylketonuria.

Authors:  Huiling Peng; Dawn Peck; Desirée A White; Shawn E Christ
Journal:  J Inherit Metab Dis       Date:  2013-09-17       Impact factor: 4.982

Review 8.  Patterns of brain injury in inborn errors of metabolism.

Authors:  Andrea L Gropman
Journal:  Semin Pediatr Neurol       Date:  2012-12       Impact factor: 1.636

Review 9.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

Review 10.  The neuropsychiatry of inborn errors of metabolism.

Authors:  Mark Walterfang; Olivier Bonnot; Ramon Mocellin; Dennis Velakoulis
Journal:  J Inherit Metab Dis       Date:  2013-05-23       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.